Loading...
NPI 1306846753 · Scarborough, ME · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Nordx is a clinical medical laboratory provider located in Scarborough, Maine. This profile covers 308 Medicare and 257 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Nordx |
| Address | 301a Us Route 1 |
| City | Scarborough |
| State | ME |
| ZIP | 04074 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | July 28, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $21.8M |
| Medicare | $2.4M |
Medicaid dominates this provider’s payer mix: NORDX reported $21.8M in total Medicaid revenue versus $2.4M in total Medicare revenue, indicating Medicaid is the primary revenue source by scale. This means any analysis of network impact or contracting should prioritize Medicaid billing patterns and reimbursement dynamics.
The code mix shows NORDX operates as a high-throughput clinical laboratory offering a broad menu of routine chemistry/hematology, infectious disease molecular testing, and definitive drug testing. Medicare top codes include specimen collection (36415), comprehensive metabolic panel (80053), and TSH (84443), while Medicaid volumes are heavily concentrated in molecular SARS-CoV-2 testing (U0003, U0005) and definitive drug testing (G0480, 80307), consistent with a centralized lab that services large screening and public-health testing programs.
Revenue concentration differs sharply by payer: the top three Medicare codes account for 31.3% of Medicare revenue, suggesting Medicare revenue is distributed across many test types, while the top three Medicaid codes account for 54.7% of Medicaid revenue, indicating Medicaid revenue is much more concentrated in a handful of high-volume services. In particular, U0003 alone represents $6.7M and 39.1% of Medicaid revenue, making it the single largest Medicaid revenue driver.
NORDX is a dominant in-state performer for many Medicaid codes: multiple tests rank #1 in-state and are labeled “extreme outlier, far above typical state volume,” including U0003 (rank #1 of 35, 100th percentile), U0005 (rank #1 of 31, 100th percentile), and several routine assays like 84443 and 82306. This statewide leadership across both molecular COVID testing and routine diagnostics suggests NORDX has either large institutional contracts, public-health arrangements, or scale advantages that drive exceptional Medicaid throughput.
Nationally on Medicare, NORDX shows pockets of very high relative activity but a mixed profile by test type. For example, 36415 ranks #112 of 86,467 providers (100th percentile) and 80048 ranks #83 of 14,725 providers (99th percentile), indicating specimen collection and some routine panels are performed at volumes well above typical national peers; by contrast its Medicare SARS-CoV-2 U0003 activity sits at rank #197 of 973 providers (80th percentile), which is elevated but not a national outlier.
Operationally, claim counts indicate large-scale specimen processing and collection workflows: Medicaid shows 199.8K claims for 36415 and 121.1K claims for U0003, while other high-count Medicaid codes include 135.1K claims for 80053 and 116.4K claims for 85025. Those volumes are consistent with centralized phlebotomy logistics and high-throughput analytical capacity that can handle both routine ambulatory testing and mass infectious-disease screening.
The provider’s Medicaid revenue profile carries concentration risk tied to public-health testing demand and reimbursement policy: U0003 ($6.7M) and U0005 ($1.2M) together are major Medicaid drivers and, along with G0480 ($1.5M), are part of the top-three Medicaid bundle that accounts for 54.7% of Medicaid revenue. Any changes to SARS-CoV-2 testing demand, coding guidance, or state payment policies could materially affect overall revenue given this concentration.
NORDX is an established entity with longevity in the dataset: its NPI was enumerated on 2005-07-28 (~21 years ago), supporting the interpretation that the lab’s elevated in-state Medicaid footprint and high claim volumes reflect sustained operations and likely longstanding payer relationships rather than a short-term spike.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
308 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 24,210 | $10 | $193.7K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 17,350 | $10 | $173.5K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 7,700 | $20 | $123.2K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 13,940 | $10 | $111.5K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 8,250 | $10 | $107.2K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 3,390 | $30 | $98.3K |
| 80048 | The lab analyst performs a basic metabolic pane (BMP) test in which he measures the blood level of eight chemicals including total calcium, sodium, potassium, chloride, carbon dioxide, glucose, blood… | 9,970 | $10 | $79.7K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 1,000 | $70 | $74.1K |
| 83970 | Parathyroid hormone test measures the level of PTH in the blood. This test is done to ascertain the level of calcium and evaluate the parathyroid function. | 1,800 | $40 | $71.9K |
| 87636 | The lab analyst performs the technical steps to detect and differentiate severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2), influenza A, and influenza B using a multiplex amplified nucleic… | 360 | $140 | $49.3K |
Showing 1–10 of 308
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 308 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
308 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| U0003 | 1 | 10 | 1,000 | $70 | $73.6K |
| 88185 | 1 | 10 | 1,990 | $20 | $37.4K |
| 88305 | 24 | 60 | 480 | $30 | $28.8K |
| 87636 | 1 | 10 | 190 | $140 | $26.2K |
| G0480 | 1 | 10 | 150 | $110 | $17K |
| 84403 | 1 | 10 | 650 | $30 | $16.3K |
| 86480 | 1 | 10 | 250 | $60 | $14.8K |
| 86807 | 1 | 10 | 180 | $70 | $13.1K |
| P9603 | 1 | 10 | 11,640 | $1 | $12.6K |
| U0005 | 1 | 10 | 510 | $20 | $12.4K |
Showing 1–10 of 308
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
257 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 121,100 | $60 | $6.7M |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 24,290 | $60 | $1.5M |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 86,430 | $10 | $1.2M |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 28,810 | $30 | $950.8K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 82,030 | $10 | $902.3K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 135,060 | $10 | $810.3K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 72,930 | $10 | $583.4K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 116,400 | $10 | $582K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 31,390 | $20 | $565.1K |
| 87389 | The lab analyst performs a test to screen for human immunodeficiency virus, called HIV. The test screens for antigens of the HIV 1 virus and antibodies to the HIV 1 and HIV 2 viruses using an… | 19,380 | $20 | $348.8K |
Showing 1–10 of 257
How this provider's Medicaid billing volume and revenue compare to other Maine providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Maine median
257 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 1 | 40 | 1,090 | $50 | $285.2K |
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 20 | 50 | 2,110 | $20 | $123K |
| 87636 | The lab analyst performs the technical steps to detect and differentiate severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2), influenza A, and influenza B using a multiplex amplified nucleic… | 20 | 30 | 2,740 | $40 | $102.8K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 2 | 40 | 1,260 | $20 | $96.8K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 2 | 40 | 2,130 | $20 | $89.9K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 1 | 30 | 2,400 | $10 | $75.3K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 1 | 50 | 7,130 | $10 | $58.6K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 2 | 60 | 12,710 | $1 | $57.8K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 1 | 60 | 6,050 | $10 | $47.4K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 1 | 50 | 3,090 | $10 | $45.8K |
Showing 1–10 of 257
Other providers in the same ZIP code as Nordx, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.